Hypoxia-induced release of peptide growth factors from neonatal porcine pulmonary artery smooth muscle cells

Biology of the Neonate

Volumn 76, Issue 5, 1999, Pages 311-319

  Ambalavanan, Namasivayam ^a   Bulger, Arlene ^a   Philips III, Joseph B ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Department of Pediatrics   (United States)

Author keywords

Cell culture; Endothelin; Fibroblast growth factor; Hypoxia; Platelet derived growth factor; Pulmonary vasculature; Vascular endothelial growth factor; Vascular smooth muscle cell

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIN 1; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HYPOXIA; NEWBORN; NEWBORN PERIOD; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PULMONARY ARTERY; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0032825073     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014173     Document Type: Article

References (33)

1. Stenmark KR, Mecham RP: Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 1997;59:89-144.
2. Dempsey EC, Das M, Frid MG, Stenmark KR: Unique growth properties of neonatal pulmonary vascular cells: Importance of time- and site-specific responses, cell-cell interaction, and synergy. J Perinatol 1996;16:S2-S11.
3. Slavin J: Fibroblast growth factors: At the heart of angiogenesis. Cell Biol Int 1995;19:431-444.
4. Battistini B, Chailler P, D'Orleans-Juste P, Briere N, Sirois P: Growth regulatory properties of endothelins. Peptides 1993;14:385-399.
5. Katayose D, Ohe M, Yamauchi K, Ogata M, Shirato K, Fujita H, Shibahara S, Takishima T: Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am J Physiol 1993;264:L100-L106.
6. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW: The vascular endothelial growth factor family or polypeptides. J Cell Biochem 1991; 47:211-218.
7. Davies P, Patton W: Peripheral and central vascular smooth muscle cells from rat lung exhibit different cytoskeletal protein profiles but similar growth factor requirements. J Cell Physiol 1994;159:399-406.
8. Roberts AB, Sporn MB: Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta. Am Rev Respir Dis 1989;140: 1126-1128.
9. Steinhorn RH, Millard SL, Morin FC III: Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment. Clin Perinatol 1995;22:405-428.
10. Bonvallet ST, Zamora MR, Hasunu-ma K, Hanasato N, Sato K, Stelzner TJ: BQ 123 an ETA receptor antagonist attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 1994;266:H1327-H1331.
11. Klekamp JG, Jarzecka K, Hoover RL, Summar ML, Redmond N, Perkett EA: Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr Res 1997;42:744-749.
12. Dempsey EC, Badesch DB, Dobyns EL, Stenmark KR: Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: Dependence on cell size, time from birth, insulin-like growth factor 1, and auto-activation of protein kinase C. J Cell Physiol 1994;160: 469-481.
13. Niinikoski J, Heughan C, Hunt TK: Oxygen tensions in the aortic wall of normal rabbits. Atherosclerosis 1973;17:353-359.
14. McKay I: Appendix 1: in McKay I, Leigh I (eds): Growth Factors. A Practical Approach. London, Oxford University Press, 1993, pp 237-243.
15. Philips JB III, Lyrene RK, Godoy G, Graybar B, Barefield E, Sams JE, Gray BM: Hemodynamic responses of chronically instrumented piglets to bolus injections of group B streptococci. Pediatr Res 1988;23:81-85.
16. Li JX, Oliver JR, Lu CY, Philips JB III: Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia. Am J Med Sci 1995; 310:103-110.
17. Benitz WE, Coulson JD, Lessler DS, Bernfield M: Hypoxia inhibits proliferation of fetal pulmonary arterial smooth muscle cells in vitro. Pediatr Res 1986;20:966-972.
18. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, Stenmark KR: Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 1995;96: 273-281.
19. Weich HA, Iberg N, Klagsbrun M, Folkman J: Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth and muscle cells. Growth Factors 1990;2:313-320.
20. Schwartz SM, Liaw L: Growth control and morphogenesis in the development and pathology of arteries. J Cardiovasc Pharmacol 1993; 21(suppl 1):S31-49.
21. Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652.
22. Ku PT, D'Amore PA: Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J Cell Biochem 1995;58:328-343.
23. D'Amore PA, Smith SR: Growth factor effects on cells of the vascular wall: A survey. Growth Factors 1993;8:61-75.
24. Libby P, Warner SJ, Salomon RN, Birinyi LK: Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 1988;318: 1493-1498.
25. Martin JF, Booth RF, Moncada S: Arterial wall hypoxia following hyperfusion through the vasa vasorum is an initial lesion in atherosclerosis. Eur J Clin Invest 1990;20:588-592.
26. Quinn DA, Dahlberg CG, Bonventre JP, Scheid CR, Honeyman T, Joseph PM, Thompson BT, Hales CA: The role of Na+/H+ exchange and growth factors in pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 1996;14:139-145.
27. Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993;264:C995-C1002.
28. Voelkel NF, Hoeper M, Maloney J, Tuder RM: Vascular endothelial growth factor in pulmonary hypertension. Ann NY Acad Sci 1996; 796:186-193.
29. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761-19766.
30. Shima DT, Deutsch U, D'Amore PA: Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203-208.
31. Hahn AWA, Resink TJ, Mackie E, Scott-Burden T, Buhler FR: Effects of peptide vasoconstrictors on vessel structure. Am J Med 1993;94/4A: 13S-19S.
32. Resink TJ, Hahn AWA, Scott-Burden T, Powell J, Weber E, Buhler FR: Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 190;168:1303-1310.
33. DiCarlo VS, Chen SJ, Meng QC, Durand J, Yano M, Chen YF, Oparil S: ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol 1995;269:L690-L697.